Wieslaw Bochenek

Trials

Studies that name Wieslaw Bochenek as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:32 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT03420781 · A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

  Allergan · terminated · Gastroparesis, Diabetes Mellitus · study director
• Ph4
  NCT02590432 · An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

  Forest Laboratories · completed · Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation · study director
• Ph2
  NCT02357420 · Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

  Allergan · completed · Diabetes Mellitus, Diabetes Mellitus Complications, Gastroparesis · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.